Identical twins are co-valedictorians in Hampton
HAMPTON, Va. (WAVY) – Graduation for Hampton High School is on Friday, and those in attendance are in for a treat! This year, the honor of Valedictorian has a very unique twist.
17-year-old Nirmani Brahmbhatt is excited for her high school graduation this year.
'I think it's just going to be a really proud moment,' said Nirmani.
Nirmani was named valedictorian. She has always been in a back and forth competition academically for the honor with another student at the school.
'We did have a friendly competition, but it was not, like, really intense.'
That friendly competitor just happens to be her identical twin sister, Nishtha.
'We always had a really small gap between our GPA. So, it was always like, who's going to be one? Who's going to be two?' said Nishtha.
Well, guess what? These sisters, born only 60 seconds apart, are both number one! For the first time in Hampton High School history, this year's graduation will have identical twin co-valedictorians!
'I really do feel like we're both inseparable,' said Nirmani.
Nishtha and Nirmani are first generation Americans. Their parents moved to the United States from India.
'They've always been working so hard for like us to get where we are, and they also like working to be financially stable here. So, for us to be able to be valedictorian is kind of like, you know, we can now like from now on, we can support them and we can like have a bright future for them as well,' said Nishtha.
Nishtha and Nirmani both plan to go to Old Dominion University. Nishtha's major is mechanical engineering. Nirmani plans to become a software engineer.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
16 hours ago
- New York Post
Bill Gates shares ‘next phase of Alzheimer's fight' as he speaks about his father's personal battle
Bill Gates is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. In an essay published this week on his blog at the Microsoft co-founder and tech billionaire, 69, reflected on the difficulty of spending another Father's Day without his dad, Bill Gates Sr. Advertisement The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. 'It was a brutal experience, watching my brilliant, loving father go downhill and disappear,' Gates wrote in the blog post. Today, motivated by his own experience with the common dementia, Gates — who serves as chair of the Gates Foundation — is committed to working toward a cure for the common dementia, which currently affects more than seven million Americans, or one in nine people over 65. In his blog, Gates expressed optimism about the 'massive progress' being made in the fight against Alzheimer's and other dementias. Advertisement Last year, Gates said he visited Indiana University's School of Medicine in Indianapolis to tour the labs where teams have been researching Alzheimer's biomarkers. 5 Bill Gates (left) is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. Brian Ach 'I also got the opportunity to look under the hood of new automated machines that will soon be running diagnostics around the world,' he wrote. 'It's an exciting time in a challenging space.' One of the biggest breakthroughs in Alzheimer's research, according to Gates, is blood-based diagnostic tests, which detect the ratio of amyloid plaques in the brain. (Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer's.) Advertisement 'I'm optimistic that these tests will be a game-changer,' Gates wrote. 5 The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. Bloomberg via Getty Images Last month, the U.S. Food and Drug Administration (FDA) approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. Traditionally, Gates noted, the primary path to Alzheimer's diagnosis was either a PET scan (medical imaging) or spinal tap (lumbar puncture), which were usually only performed when symptoms emerged. Advertisement The hope is that blood-based tests could do a better job of catching the disease early, decline begins. 5 Last month, the U.S. Food and Drug Administration approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. – 'We now know that the disease begins 15 to 20 years before you start to see any signs,' Gates wrote. 'A simple, accurate and easy-to-run blood test might one day make routine screening possible, identifying patients long before they experience cognitive decline,' he stated. Gates said he is often asked, 'What is the point of getting diagnosed if I can't do anything about it?' Start and end your day informed with our newsletters Morning Report and Evening Update: Your source for today's top stories Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters To that end, he expressed his optimism for the future of Alzheimer's treatments, noting that two drugs — Lecanemab (Leqembi) and Donanemab (Kisunla) — have gained FDA approval. 'Both have proven to modestly slow down the progression of the disease, but what I'm really excited about is their potential when paired with an early diagnostic,' Gates noted. Advertisement He said he is also hopeful that the blood tests will help speed up the process of enrolling patients in clinical trials for new Alzheimer's drugs. 5 The hope is that blood-based tests could do a better job of catching the disease early, decline begins. Monkey Business – To accomplish this, Gates is calling for increased funding for research, which often comes from federal grants. 'This is the moment to spend more money on research, not less,' he wrote, also stating that 'the quest to stop Alzheimer's has never had more momentum.' Advertisement 'There is still a huge amount of work to be done — like deepening our understanding of the disease's pathology and developing even better diagnostics,' Gates went on. 5 Microsoft Chairman Bill Gates, his wife Melinda, far left, his father Bill Gates Sr., and his step-mother Mimi Gates pose for a photo in 2007. AP Gates pointed out that when his father had Alzheimer's, it was considered a 'death sentence,' but that is starting to change. Advertisement 'I am blown away by how much we have learned about Alzheimer's over the last couple of years,' he wrote. 'I cannot help but be filled with a sense of hope when I think of all the progress being made on Alzheimer's, even with so many challenges happening around the world. We are closer than ever before to a world where no one has to watch someone they love suffer from this awful disease.'
The Hill
a day ago
- The Hill
ChatGPT use linked to cognitive decline: MIT research
ChatGPT can harm an individual's critical thinking over time, a new study suggests. Researchers at MIT's Media Lab asked subjects to write several SAT essays and separated subjects into three groups — using OpenAI's ChatGPT, using Google's search engine and using nothing, which they called the 'brain‑only' group. Each subject's brain was monitored through electroencephalography (EEG), which measured the writer's brain activity through multiple regions in the brain. They discovered that subjects who used ChatGPT over a few months had the lowest brain engagement and 'consistently underperformed at neural, linguistic, and behavioral levels,' according to the study. The study found that the ChatGPT group initially used the large language model, or LLM, to ask structural questions for their essay, but near the end of the study, they were more likely to copy and paste their essay. Those who used Google's search engine were found to have moderate brain engagement, but the 'brain-only' group showed the 'strongest, wide-ranging networks.' The findings suggest that using LLMs can harm a user's cognitive function over time, especially in younger users. It comes as educators continue to navigate teaching when AI is increasingly accessible for cheating. 'What really motivated me to put it out now before waiting for a full peer review is that I am afraid in 6-8 months, there will be some policymaker who decides, 'let's do GPT kindergarten.' I think that would be absolutely bad and detrimental,' the study's main author Nataliya Kosmyna told TIME. 'Developing brains are at the highest risk.' However, using AI in education doesn't appear to be slowing down. In April, President Trump signed an executive order that aims to incorporate AI into U.S. classrooms. 'The basic idea of this executive order is to ensure that we properly train the workforce of the future by ensuring that school children, young Americans, are adequately trained in AI tools, so that they can be competitive in the economy years from now into the future, as AI becomes a bigger and bigger deal,' Will Scharf, White House staff secretary, said at the time.
Business Insider
2 days ago
- Business Insider
Gen Z is ditching alcohol, but their weed habit may be risky for their health, too
Gen Z may be cutting back on booze, but could still be facing serious health risks from their new drug of choice. Cannabis use has been steadily growing in recent years, and Gallup polls suggest it's catching on most with Americans aged 18 to 34. At the same time, 20-somethings are spending less time and money than ever in bars and liquor stores (and worrying alcohol industry leaders), in part because of a growing movement of health-consciousness. Sinking alcohol sales in recent years have coincided with a renewed focus on the health risks of drinking, including the link between any amount of alcohol use and cancer. With an outpouring of products like THC-infused seltzers, mocktails, and tinctures that offer a buzz without the hangover, the cannabis industry is capitalizing on dwindling interest in alcohol. These alternatives cater to young people who are sober-curious, drinking less without abstaining completely, or " Cali sober," giving up alcohol while still consuming cannabis. However, emerging research suggests alternatives like cannabis aren't risk-free either Using cannabis may double your risk of dying from cardiovascular disease, according to a large study published June 17 in the journal Heart. Researchers from the University of Toulouse looked at data from 24 studies, including about 200 million people primarily between ages 19 and 59, to see how cannabis use affected health over time. They found that cannabis users had a 29% higher risk of heart attack, and a 20% higher risk of stroke, compared to peers who didn't use. A striking number of these patients who were hospitalized for heart problems are young and did not have a prior history of related medical issues or risk factors, the study's senior author Émilie Jouanjus, associate professor of pharmacology at the University of Toulouse, told CNN. Edibles may not be risk-free, either. Previous research found that ingesting THC, the active ingredient in cannabis linked to the sensation of being high, is linked to cellular dysfunction, which increases risks to heart health, even if you don't smoke it. The findings add to a growing body of research suggesting that although cannabis isn't the outsize threat presented during the "Reefer Madness" era, it has significant health risks, and scientists are urging more caution from consumers. An editorial published alongside the most recent study calls for a closer look at regulation of the emerging cannabis market, including warning labels similar to those on cigarettes. "Regulation is focused on establishing the legal market with woeful neglect of minimizing health risks," the authors wrote. "Specifically, cannabis should be treated like tobacco: not criminalized but discouraged."
